Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BA + Esketamine for TRD
NCT06431386Terminated
- Sponsor
- University of Ottawa Institute of Mental Health Research at The Royal
- Start
- Jun 2024
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by University of Ottawa Institute of Mental Health Research at The Royal. Primary endpoint: Change in depressive symptoms at 12 weeks. Started Jun 2024; status: terminated.
Beyond the preview
Go deeper on NCT06431386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06431386.